Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1841-1850 of 2867 for cancer

Edit search filters
  1. A Study To Test Nivolumab With Usual Chemotherapy Treatment Or Usual Chemotherapy Treatment Alone To Treat Recurrent Or Metastatic Nasopharyngeal Cancer

    Jacksonville, FL, Rochester, MN

  2. Phase II Trial Of Standard Chemotherapy +Various Proton Beam Therapy (PBT) Doses For Unresectable Stage 2/3 Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Irinotecan And Cetuximab With Or Without Bevacizumab In Treating Patients With RAS Wild-Type Locally Advanced Or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ

  4. Pharmacokinetic And Safety Study Of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine In Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia

    Scottsdale/Phoenix, AZ

  5. DAREON™-5: A Study To Test Whether Different Doses Of BI 764532 Help People With Small Cell Lung Cancer Or Other Neuroendocrine Cancers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Study Of Two Doses Of MK-3475 (Pembrolizumab) Versus Docetaxel In Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

    Rochester, MN

  7. Phase II Trial Of Irinotecan, Cetuximab, And Bevacizumab Compared With Irinotecan, Cetuximab, And Placebo In KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer

    Rochester, MN

  8. A Randomized, Double-blind, Phase 3 Efficacy Trial Of PROSTVAC-V/F +/- GM-CSF In Men With Asymptomatic Or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

    Rochester, MN

  9. A Study To Evaluate Treating Post-Mastectomy Radiation Injury In Breast Cancer Patients With Adipose-Induced Regeneration Of Breast Skin (AIR Breast)

    Jacksonville, FL

  10. A Randomized Study Of Olaparib Or Placebo In Patients With Surgically Removed Pancreatic Cancer Who Have A BRCA1, BRCA2 Or PALB2 Mutation, The APOLLO Trial

    Rochester, MN

.

Mayo Clinic Footer